Story perspectives

EU Receives First Favipiravir Doses Amid Cruise Hantavirus Outbreak

5/28/2026

Summary

Story summary

European Commission announced the first shipment of experimental favipiravir doses to France, Spain and the Netherlands after Fujifilm Pharmaceuticals donated 1,400 tablets to the European Union (EU).
European Medicines Agency named favipiravir the most plausible hantavirus treatment under clinical-trial or compassionate-use protocols.
Thirteen cruise-ship-linked hantavirus cases have been confirmed in six countries, prompting the EU to start emergency procurement of additional favipiravir doses.

1 of 1

Story summary

European Commission announced the first shipment of experimental favipiravir doses to France, Spain and the Netherlands after Fujifilm Pharmaceuticals donated 1,400 tablets to the European Union (EU).
European Medicines Agency named favipiravir the most plausible hantavirus treatment under clinical-trial or compassionate-use protocols.
Thirteen cruise-ship-linked hantavirus cases have been confirmed in six countries, prompting the EU to start emergency procurement of additional favipiravir doses.